| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/SJI.12553 |
| P698 | PubMed publication ID | 28387980 |
| P50 | author | Gayatri Ramakrishna | Q57560354 |
| Nirupma Trehanpati | Q87824544 | ||
| P2093 | author name string | A Jindal | |
| A K Vyas | |||
| S Hissar | |||
| P2860 | cites work | Vaccine-induced escape mutant of hepatitis B virus | Q45860147 |
| Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients | Q46798240 | ||
| [Do the interferons have an antifibrotic action? The hepatologist's point of view]. | Q50583785 | ||
| Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. | Q51907093 | ||
| A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B | Q56881033 | ||
| Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp | Q57236198 | ||
| Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus | Q21128797 | ||
| CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma | Q24568172 | ||
| Epidemiology and Prevention of Hepatitis B Virus Infection | Q24810152 | ||
| NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma | Q27001052 | ||
| Stealth and cunning: hepatitis B and hepatitis C viruses | Q27470232 | ||
| Comparison of efficacy and safety of tenofovir and entecavir in chronic hepatitis B virus infection: a systematic review and meta-analysis | Q28539472 | ||
| Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands | Q28972540 | ||
| EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 | ||
| Engineering human IL-18 with increased bioactivity and bioavailability | Q33245598 | ||
| Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus | Q33566365 | ||
| Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection | Q33725558 | ||
| Human cytomegalovirus elicits fetal gammadelta T cell responses in utero | Q33795023 | ||
| B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure | Q33928288 | ||
| Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. | Q33931634 | ||
| Dendritic cells in uninfected infants born to hepatitis B virus-positive mothers | Q33962727 | ||
| Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition | Q34281819 | ||
| Role of LAG-3 in regulatory T cells. | Q34358935 | ||
| Combination treatment in HBeAg-negative chronic hepatitis B. | Q34391476 | ||
| Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. | Q34439778 | ||
| Epidemiology of hepatitis B virus infection in India | Q34441971 | ||
| Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). | Q34693445 | ||
| The immunology of hepatitis B. | Q34709116 | ||
| Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy | Q34742036 | ||
| Tackling the Hepatitis B Disease Burden in India | Q34983470 | ||
| Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study | Q35011097 | ||
| Defective natural killer cell anti-viral capacity in paediatric HBV infection | Q35111394 | ||
| Trained immunity in newborn infants of HBV-infected mothers | Q35311846 | ||
| Novel DNA vaccine based on hepatitis B virus core gene induces specific immune responses in Balb/c mice | Q35435556 | ||
| Viral hepatitis B. | Q35617319 | ||
| Hepatitis B virus translocates across a trophoblastic barrier. | Q35914415 | ||
| Immunomodulatory therapy for chronic hepatitis B virus infection | Q36014956 | ||
| The cross-regulatory relationship between human dendritic and regulatory T cells and its role in type 1 diabetes mellitus | Q36084610 | ||
| Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients | Q36302694 | ||
| CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses | Q36371702 | ||
| Innate immunity of the newborn: basic mechanisms and clinical correlates | Q36800979 | ||
| GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees | Q36950984 | ||
| Antiviral resistance and hepatitis B therapy | Q37255008 | ||
| Long-lasting memory T cell responses following self-limited acute hepatitis B | Q37359318 | ||
| Reactivation of hepatitis B. | Q37462566 | ||
| An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases | Q37562042 | ||
| Cyclophilin A: a key player for human disease | Q37577487 | ||
| Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. | Q37638204 | ||
| Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide | Q37643774 | ||
| Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers | Q37729188 | ||
| Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses | Q38270733 | ||
| Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities | Q38532736 | ||
| Cytokines elevated in patients with HBV-related acute-on-chronic liver failure promote NK cell mediated cytotoxicity through TRAIL. | Q38795432 | ||
| Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. | Q39021951 | ||
| Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. | Q39042899 | ||
| Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B. | Q39187780 | ||
| Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. | Q39329221 | ||
| Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load | Q39681674 | ||
| Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein | Q40190769 | ||
| RNAi-based knockdown of HBx mRNA in HBx-transformed and HBV-producing human liver cells | Q40254411 | ||
| Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads. | Q41670611 | ||
| Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production | Q41705394 | ||
| Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in Hepatitis B virus-positive newborns | Q42287415 | ||
| Kupffer cells express a unique combination of phenotypic and functional characteristics compared with splenic and peritoneal macrophages. | Q42507770 | ||
| Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function | Q42614451 | ||
| Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure | Q42953540 | ||
| Impaired antigen processing and presentation machinery is associated with immunotolerant state in chronic hepatitis B virus infection | Q43124202 | ||
| Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. | Q43258398 | ||
| Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. | Q43695474 | ||
| Beneficial effects of 'lamivudine pulse' therapy in HBeAg-positive patients with normal ALT*. | Q43934379 | ||
| Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection | Q44489299 | ||
| Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states | Q45359450 | ||
| Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen | Q45361066 | ||
| Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant women in India | Q45367264 | ||
| Clinical significance of hepatitis B surface antigen in cord blood of hepatitis B e-antigen-negative chronic hepatitis B virus-infected mothers | Q45384233 | ||
| Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge | Q45420571 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 4-14 | |
| P577 | publication date | 2017-04-07 | |
| P1433 | published in | Scandinavian Journal of Immunology | Q15762682 |
| P1476 | title | Immune balance in Hepatitis B Infection: Present and Future Therapies | |
| P478 | volume | 86 |
Search more.